ArticleFrontiers in psychiatry2025
Psychopathy dimensions and substance use: evidence from a non-institutionalized adult population.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mental health in Lebanon has been profoundly affected by recent crises, altering the patterns of substance use and psychiatric presentations. In this context, the link between psychopathy and substance use is relevant, but is underexplored in Arab cultural settings. This study aimed to assess the relationship between psychopathy and substance use in the Arab world, focusing on whether individuals in a Lebanese non-institutionalized population who use substances have higher psychopathy traits than those who do not. Methods: This is a cross-sectional study conducted among 534 non-institutionalized Lebanese adults between May and June 2021. Participants completed a self-administered questionnaire including the validated Levenson Self-Report Psychopathy (LSRP) scale, TAPS (the Tobacco, Alcohol, Prescription medication, and Other substance use screener), the short version of the Urgency, Premeditation (lack of), Perseverance (lack of), Sensation Seeking, Positive Urgency, Impulsive Behavior scale (S-UPPS-P), and the Adverse Childhood Experiences (ACE) questionnaire. Bivariate analysis and multivariable regression were used to assess the association between psychopathy traits and substance use, adjusting for relevant factors. Results: The mean age of the participants was 36.58 ± 11.94 years, and approximately 80% were women. Callousness was linked with tobacco, alcohol, and illicit drug use, while antisocial traits were associated with tobacco and prescription drug misuse. The regression analyses revealed that the antisocial factor was robustly associated with overall substance use (OR = 1.07, 95% CI = 1.01-1.14, p = 0.02), including tobacco use (OR = 1.13, 95% CI = 1.05-1.21, p = 0.001) and prescription drug misuse (OR = 1.28, 95% CI = 1.14-1.43, p < 0.001). Moreover, it showed that callousness significantly increased the odds of alcohol (OR = 1.15, 95% CI = 1.05-1.26, p = 0.003) and illicit drug use (OR = 1.13, 95% CI = 1.03-1.24, p = 0.01). Discussion: This is the first study that examined the relationship between substance use and psychopathy traits in a Lebanese population. These results argue for trait-specific interventions to improve the efficacy and cost-effectiveness of substance use prevention and rehabilitation programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.